+375.2%
MRNA vs VG
-49.2%
+424.4%
-50.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | VG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | -3.7% | -1.2% | -4.8% |
| 7D | -20.9% | -4.9% | -16.0% | -20.9% |
| 30D | -13.3% | -6.0% | -7.3% | -13.3% |
| 3M | +212.6% | -15.0% | +227.6% | +212.7% |
| 6M | +309.0% | -14.7% | +323.7% | +307.1% |
| YTD | +567.3% | +77.5% | +489.8% | +474.8% |
| 1Y | +689.7% | +53.7% | +636.0% | +593.8% |
| All | +375.2% | -49.2% | +424.4% | +341.5% |
Cumulative growth
Daily Returns
Daily percentage return beside VG.
Daily Out/Under-Performance
Portfolio return minus VG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded VG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling